In 1959, Phentermine was FDA approved for treatment of obesity for 90 days. Phentermine is only approved for short term use because safety data came from a short term study and at the time of its The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide A preliminary study of the physiological and perceptual effects of GLP 1 receptor agonists during alcohol consumption in people with obesity Scientific Reports Shop Glp1 Oral Online with Best Discounts and Low Prices Lazada Philippines